Virginia Economic Review

Medical Device Manufacturer Embody Sets Stage for International Growth For Norfolk-based Embody, Inc., the six-year process of product development, preclinical testing, and compliance hurdles to get its collagen-based tendon and ligament implant, Tapestry, into the U.S.

Partnership With JMU, BRCC Helps Merck Fill Need for HPV Vaccines In 2019, Melissa Lubin learned that pharmaceutical giant Merck & Co., Inc., was competing for a billion-dollar expansion in Elkton, a town in the Shenandoah Valley.

The highly transmissible omicron variant of the novel coronavirus upended perceptions about proper mitigation. People who had been wearing fabric masks began switching over to N95 and KN95 respirators, leading to greater demand for respirators.

During the COVID-19 pandemic, Virginia Tech's Rob Gourdie was busy investigating how to deliver medications more effectively.

Kimberly Kelly was a biomedical engineer at the University of Virginia (UVA), working on ways to diagnose pancreatic cancer, when she discovered a protein expressed by the cancer cells.

Universities, VA Bio+Tech Park Draw Investment to Richmond For communities seeking to recreate the success of well-known life sciences clusters in Boston, San Diego, and the San Francisco Bay Area, Genetic Engineering & Biotechnology News suggests there’s a straightforward formula to replicate.

Northern Virginia’s advantages in attracting talent are well known, from best-in-class public schools, to vibrant communities, to the attractions and sights of Washington, D.C.

Despite facing an unprecedented global pandemic, executives at GlaxoSmithKline Consumer Healthcare (GSK) were able to recruit 150 new employees for the company’s research and development center in Richmond.

Like many medical device startups, Luminoah began with a bright idea brought about by a personal need. In 2019, founder Neal Piper’s young son, Noah, had a medical issue that necessitated the use of a feeding tube.

Chandra Briggman is president and CEO of Activation Capital, an independent authority that supports life sciences and advanced technology companies and entrepreneurship in the Richmond area.

John Newby is CEO of Virginia Bio, the nonprofit statewide trade association that serves and promotes the life sciences industry in the Commonwealth.

Richmond and Petersburg Host a New Pharmaceutical Cluster Making Essential Medicines With Innovative Techniques The COVID-19 pandemic has brought shortages of all kinds to the U.S. economy, from cream cheese and toilet paper to N95 masks and consumer electronics.

The field of cybersecurity is as old as the computer, but it’s only in the past decade that it went from being a periphery issue to a cornerstone of government budgets and one of the fastest-growing career fields.

The Innovative Virginia Cyber Range is Giving Students in Virginia — and Beyond — a Chance to Hone Their Cybersecurity Skills Between 2010 and 2014, the U.S.

Virginia is a national leader in the cybersecurity and technology industries, offering tech firms access to the highest concentration of tech talent and the third-largest tech industry workforce in the country.

Steve Morgan is the founder of Cybersecurity Ventures, a leading cybersecurity research company that provides data and insights on global cybercrime to C-suite executives, and editor-in-chief of Cybercrime Magazine. Before starting the company, he worked for antivirus giant McAfee Corp.

Virginia Universities' Transdisciplinary Research is Driving Digital Security Advancements The world’s increasing connectivity offers more opportunity for cybercriminals. The FBI’s 2020 Internet Crime Report cited a 69% increase in complaints of suspected cybercrimes.

Luiz DaSilva is executive director of the Commonwealth Cyber Initiative (CCI) and Bradley Professor in Cybersecurity at Virginia Tech. Before coming to Virginia, he served as the director of CONNECT, a telecommunications research center at Trinity College Dublin.